In 2015, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA), ushering in one of the largest changes in healthcare reimbursement from the federal government, the largest single payer in the United States. For the estimated 600,000 eligible clinicians providing care under Medicare Part B, MACRA has significant implications for their reimbursement. This White Paper summarizes the changes and presents new CCO survey data that illuminate clinicians’ challenges in understanding how these complex changes may affect their practice as well as the role of continuing medical education (CME) in meeting the new requirements that MACRA introduces.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.